Global Drug Discovery Technologies Markets to 2022 - Leading Players are Agilent Technologies, Ametek, Bayer Technology Services, Bruker, Compugen and GE Healthcare Lifesciences
DUBLIN, Aug. 23, 2018 /PRNewswire/ --
The "Drug Discovery Technologies" report has been added to ResearchAndMarkets.com's offering.
The drug discovery industry has witnessed growth in the past few years owing to progress in biochemical, translational and molecular studies in biomedical research. These tools are commercially employed in the development of novel and efficient drug candidates. The booming healthcare sector and increased government funding has aided significant growth in the biomedical industry. The delineation of mechanistic details and the underlying mechanisms of drug target interaction have paved the way for more efficient and accurate therapies. The biopharmaceutical industry and various research institutes are conducting exhaustive research in the field of drug discovery.
The expanding field of drug discovery and development is allowing researchers to focus on discovering important lead compounds for various forms of cancer and other diseases. Globally, biopharmaceutical companies and research institutes are exploring several molecular and biochemical aspects to develop mechanistic approaches for drug discovery. Various tools such as high-throughput screening, proteomics and genomic tools, including quantitative reverse transcription polymerase chain reaction (qRT-PCR), next generation sequencing (NGS) and many others, are being widely used for cellular analysis.
In the last decade, the drug discovery tools market has witnessed increased usage in the biomedical industry. Applications are proteomics, next-generation sequencing and high-throughput screening tools that target cancers and other diseases, including autoimmune diseases. A rise in R&D, the growing incidences of various life-threatening diseases and the increasing global population are all market drivers. Companies are focusing on enhancing biomedical research and advancement of superior technologies in order to provide better quality of treatment and therapies. One industry source described the current drug discovery process as driven by the computational method using bioinformatic tools, followed by drug innovation in the pharmaceutical industry, plant-derived drug discoveries and, lastly, through the translation of molecules.
Collaborative efforts of researchers and the pharmaceutical industry are establishing various promising future drug candidates. Drug discovery find applications in cardiovascular, neurological, cancer and other disease areas. Some key players in this space include Thermo Fisher Scientific, Shimadzu Corp., Illumina Inc. and Bio-Rad Laboratories Ltd. Major end users of these products are research centers, academic institutions, government and private laboratories, as well as pharmaceutical, biotechnology companies and contract research organizations.
In the emerging regions, China and India, in particular, remain attractive markets for healthcare. Asian countries are attracting various pharmaceutical and biotechnological companies due to their heterogeneous patient population pool. In addition, China is now a major research center with a large number of collaborative research efforts throughout the country.
Report Includes:
- 60 data tables and 23 additional tables.
- An overview of the global markets for drug discovery technologies.
- Analyses of global market trends with data from 2015, 2016, and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environment, including new and potential venues for novel technologies and approaches.
- Descriptions of various products, such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.
- Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies across different segments of the industry.
- Comprehensive company profiles of major players in the market including Agilent Technologies Inc., Ametek Inc., Bayer Technology Services GMBH, Bruker Corp., Compugen Ltd. and GE Healthcare Lifesciences.
Key Topics Covered:
1. Introduction
2. Summary and Highlights
3. Market and Technology Background
4. Market Breakdown by Technology Type
5. Market Breakdown by End User
6. Market Breakdown by Disease
7. Market Breakdown by Region
8. Industry Structure
9. Patent Review/New Developments/Regulatory Aspects
10. Analysis of Market Opportunities
11. Company Profiles
- Agilent Technologies Inc
- Ametek Inc.
- Bayer Technology Services Gmbh
- Bio-Rad Laboratories Ltd
- Biocrates Life Sciences AG
- Biomax Informatics AG
- Biotek Instruments Inc.
- Bruker Corp.
- Carl Zeiss Microimaging Gmbh
- Compugen Ltd.
- Danaher Corp.
- Dassault Systemes
- GE Healthcare Lifesciences
- Hamilton Robotics Inc.
- Hitachi High-Technologies Corp.
- Human Metabolome Technologies Inc.
- Illumina Inc.
- Integrated Dna Technologies Inc.
- Iroa Technologies
- Jeol USA Inc.
- Leco Corp.
- Lonza Group AG
- Perkinelmer Inc.
- Promega Corp.
- Qiagen N.V.
- Roche Holding Ltd.
- Shimadzu Corp.
- Sidmap LLC
- Sigma-Aldrich Corp.
- Somalogic Inc.
- Thermo Fisher Scientific Inc.
- Waters Corp.
For more information about this report visit https://www.researchandmarkets.com/research/pnzf2b/global_drug?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article